Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection


A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants.

Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which in this case was Uganda or South Africa.

The results were nothing short of extraordinary—100% efficacy, not a single young woman contracted HIV.

This was followed up by PURPOSE 2, which expanded the geographical area significantly to more countries on more continents, and expanded the pool of individuals from beyond just young women to men—and to those of all ages. 5,000 participants took part.

The result was the same: 99.9% reduction in infection rates.

Both were considered phase 3 clinical trials, and were conducted in a randomized, double-blinded protocol, but were not tested against a placebo. Instead, the Lenacapavir injections were compared to the current standard of HIV prevention—a pill called Truvada or Descovy taken daily.

These both were also found to prevent HIV transmission by 99.9% during development, but must be taken every day to achieve this level of protection. As anyone who’s tried to stick to a once-a-day pill regime long-term will agree, it’s not an easy thing to maintain month after month.

By contrast, the twice-yearly injections are much easier to adhere to, and they also come with the added benefit of removing the social stigma of being seen taking a daily pill and therefore at risk of HIV transmission. This can be particularly alleviating in high-HIV-prevalent countries where male homosexuality is illegal, such as Uganda.

Indeed the superiority of a twice-yearly injection was so clear that both PURPOSE trials were halted early over ethical reasons. A 52-week follow-up screened for HIV developments.

Lenacapavir was named by Science Magazine as the Breakthrough of the Year in 2024, and was approved by the FDA for use in humans under the brand name Yeztugo.

It works to break down the HIVs capsid shell by binding to an “highly conserved” protein on the exterior. That means that no matter how many times or into what form the virus mutates, the exterior shell protein remains—presenting the perfect target for the drug.

In layman’s terms, the drug then works through the protein to disrupt the capsid shell, which the virus ‘takes down’ and ‘builds up’ several times during its lifecycle with perfect geometric precision. The disruption prevents the virus from completing its life cycle.

Initial R&D, regulation compliance, and proof of efficacy and safety requirements mean that producing Lenacapavir has cost its developer, Gilead Sciences, an undisclosed total cost that would be reasonable to estimate at well over a billion dollars based on normal pharma development costs.Gilead has nevertheless committed to providing the drug at cost in certain low-income regions and has licensed generic manufacturers to produce it for approximately $40 per year in 120 low and middle-income countries starting in 2027 Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
Read More........

Papua New Guinea Sets Up Protected Ocean the Size of UK–Over 77,000 Square Miles

Acropora latistella (Table coral) in the Coral Triangle – credit, Nhobgood Nick Hobgood CC 3.0. SA

In the legendary Coral Triangle, where the Pacific and Indian Oceans meet, 200,000 square kilometers of tropical seas will be off limits to fishing thanks to bold conservation action by Papua New Guinea.

The newly-designated Western Manus Marine Protected Area (MPA) will form part of the newly established Melanesian Ocean Corridor of Reserves, a network of national and jointly managed protected areas spanning Fiji, Vanuatu, and Papua New Guinea.

Revealed at the inaugural Melanesian Ocean Summit in Port Moresby in mid-May, the Western Manus ocean region in PNG’s territorial waters is characterized by undersea mountains and volcanoes, ridgelines, and canyons, harboring remarkable biodiversity.

Scientists have called it a “marine highway” connecting shallow corals with deep water zones bursting with pelagic life: orcas that migrate there seasonally, the giant deep-sea fish known as a yokozuna slickhead, Cuvier’s beaked whale, and over a hundred species of coral.

“Papua New Guinea is one of the most biodiverse places on the planet,” said Jelta Wong, minister of the country’s National Fisheries Authority. “Establishing the Western Manus Marine Protected Area will allow us to preserve and protect our ecological legacy and, at the same time, ensure that our ocean continues to provide people with what we need – food and a source of income.”

Located in the north of PNG’s territorial waters, the 77,000 square-mile reserve covers seas which account for 10% of the country’s tuna fisheries, and about 6.7% of all fishing output. However, as Oceanographic Magazine writes, previous research has found that once MPAs have been established, catch rates tend to increase in boundary areas—the result of a spillover effect from a robust and unharmed natural environment.

The decision comes as part of PNG’s commitment to conserve 30% of its territorial waters.

The Western Manus area was included in the survey itinerary of the National Geographic Pristine Sea’s expedition, which sought to document the biodiversity of the Coral Triangle over 2 years.

What they found was one of the world’s healthiest and most diverse coral ecosystems, but with warning signs that not all might be well. Shark populations were low—a clear hint at overfishing for other predatory fish like tuna.

The 200,000 square kilometers that encompass the MPA weren’t selected at random. Instead, key mobile species were tracked to get a sense of the movements of animals between the deep sea and the coral reefs. Grey reef sharks obliged the surveyors, while seabirds capable of foraging 200 miles a day were also consulted.

“Our ancestors have always lived in harmony with the sea, but today, we are writing a new chapter for our children,” stated Powes Parkop, governor of the National Capital District, who grew up in Manus Province.
“To see the waters of Western Manus recognized as the largest marine protected area in Papua New Guinea fills my heart with a profound sense of… pride. We aren’t just protecting fish or coral; we are safeguarding our identity. Papua New Guinea Sets Up Protected Ocean the Size of UK–Over 77,000 Square Miles
Read More........